Sublingual immunotherapy and subcutaneous immunotherapy: Issues in the United States

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 6, 2007, Pages 1466-1468

  Greenberger, Paul A ^a   Ballow, Mark ^b,c   Casale, Thomas B ^d   Platts Mills, Thomas A E ^e   Sampson, Hugh A ^f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c CHILDREN S HOSPITAL OF BUFFALO   (United States)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; CORTICOSTEROID; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT;

ALLERGIC RHINITIS; ASTHMA; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; LETTER; MAINTENANCE THERAPY; PRIORITY JOURNAL; SYMPTOMATOLOGY; UNITED STATES;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; AMERICAN MEDICAL ASSOCIATION; DESENSITIZATION, IMMUNOLOGIC; HUMANS; INJECTIONS, SUBCUTANEOUS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 36749095849     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.08.055     Document Type: Letter

References (15)

1. Cox L.S., Larenas Linnemann D., Nolte H., Weldon D., Finegold I., and Nelson H.S. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 117 (2006) 1021-1035
2. Scadding G., and Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis to dust mite. Clin Allergy 16 (1986) 483-491
3. Malling H.-J. Sublingual immunotherapy: efficacy-methodology and outcome of clinical trials. Allergy 61 suppl 81 (2006) 24-28
4. Durham S.R., Walker S.M., Varga E.-M., Jacobson M.R., O'Brien F., Noble W., et al. Long-term clinical-efficacy of grass-pollen immunotherapy. N Engl J Med 341 (1999) 468-475
5. Durham S.R., Yang W.H., Pedersen M.R., Johansen N., and Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 802-809
6. Smith H., White P., Annila I., Poole J., Andre C., and Frew A. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 114 (2004) 831-837
7. Li J., Lockey R.F., Bernstein I.L., Portnoy J.M., and Nicklas R.A. Allergen immunotherapy: a practice parameter. Ann Allergy Asthma Immunol 90 suppl 1 (2003) 1-40
8. Bousquet J. Sublingual immunotherapy: validated!. Allergy 61 suppl 81 (2006) 5-6
9. Canonica G.W., and Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 61 suppl 81 (2006) 20-23
10. Dunsky E.H., Goldstein M.F., Dvorin D.J., and Belecanech G.A. Anaphylaxis to sublingual immunotherapy. Allergy 61 (2006) 1235
11. Eigan A.O., Keles S., Bahceciler N.N., and Barlan I.B. Anaphylaxis to multiple pollen allergen sublingual immunotherapy. Allergy 62 (2007) 567-568
12. Marogna M., Spadolini I., Massolo A., Canonica G.W., and Passalacqua G. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol 115 (2005) 1184-1188
13. Di Rienzo V., Marcucci F., Puccinelli P., Parmiani S., Frati F., Sensi L., et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 33 (2003) 206-210
14. American Medical Association. Current Procedural Terminology (CPT) 2007 professional edition (2007), American Medical Association, Chicago, Ill p. 402-3
15. Nelson H.B., Areson J., and Reisman R. A prospective assessment of the remote practice of allergy: comparison of the diagnosis of allergic disease and the recommendations for allergen immunotherapy by board-certified allergists and a laboratory performing in-vitro assays. J Allergy Clin Immunol 92 (1993) 380-386